pioglitazone

Generic: pioglitazone

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone
Generic Name pioglitazone
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pioglitazone hydrochloride 15 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-219
Product ID 57237-219_f3308268-8023-434e-8caf-734ca298b98e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200268
Listing Expiration 2026-12-31
Marketing Start 2013-02-13

Pharmacologic Class

Classes
peroxisome proliferator receptor alpha agonist [epc] peroxisome proliferator receptor gamma agonist [epc] peroxisome proliferator-activated receptor alpha agonists [moa] peroxisome proliferator-activated receptor gamma agonists [moa] thiazolidinedione [epc] thiazolidinediones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237219
Hyphenated Format 57237-219

Supplemental Identifiers

RxCUI
312440 312441 317573
UPC
0357237221303 0357237220306 0357237219300
UNII
JQT35NPK6C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone (source: ndc)
Generic Name pioglitazone (source: ndc)
Application Number ANDA200268 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 BOTTLE (57237-219-05)
  • 30 TABLET in 1 BOTTLE (57237-219-30)
  • 90 TABLET in 1 BOTTLE (57237-219-90)
source: ndc

Packages (3)

57237-219-05 500 TABLET in 1 BOTTLE (57237-219-05) 57237-219-30 30 TABLET in 1 BOTTLE (57237-219-30) 57237-219-90 90 TABLET in 1 BOTTLE (57237-219-90)

Ingredients (1)

pioglitazone hydrochloride (15 mg/1)

Linked Drug Pages (1)

Pioglitazone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f3308268-8023-434e-8caf-734ca298b98e", "openfda": {"upc": ["0357237221303", "0357237220306", "0357237219300"], "unii": ["JQT35NPK6C"], "rxcui": ["312440", "312441", "317573"], "spl_set_id": ["4483b1c6-7095-4a63-8128-ac2d91e11040"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (57237-219-05)", "package_ndc": "57237-219-05", "marketing_start_date": "20130213"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (57237-219-30)", "package_ndc": "57237-219-30", "marketing_start_date": "20130213"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (57237-219-90)", "package_ndc": "57237-219-90", "marketing_start_date": "20190612"}], "brand_name": "Pioglitazone", "product_id": "57237-219_f3308268-8023-434e-8caf-734ca298b98e", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "57237-219", "generic_name": "Pioglitazone", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pioglitazone", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA200268", "marketing_category": "ANDA", "marketing_start_date": "20130213", "listing_expiration_date": "20261231"}